Back to search

Article

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients

2022-05-03

Abstract excerpt

<h4>Purpose: </h4> We aimed to identify the overexpressed genes or related pathways associated with good responses to anti-HER2 therapy and to suggest a model for predicting drug response in neoadjuvant systemic therapy with trastuzumab in HER2-positive breast cancer patients. <h4>Methods: </h4>: We recruited 64 women with breast cancer and categorized them into 3 groups: complete response (CR), partial response (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
060b6eb2-5bba-5ac1-8e6f-1333cacce34c
DOI
10.21203/rs.3.rs-1575402/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer PatientsDOI 10.21203/rs.3.rs-1575402/v1
Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer PatientsSemantic proximity
Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancerSemantic proximity
Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance BiomarkersSemantic proximity
A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survivalSemantic proximity
Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast CancerSemantic proximity
A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast CancerSemantic proximity
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer.Semantic proximity
Transcriptome profiling identified differentially expressed genes and pathways associated with tamoxifen resistance in human breast cancerSemantic proximity
Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast CancerSemantic proximity
Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy.Semantic proximity
Advances in EGFR/HER2-directed clinical research on breast cancer.Semantic proximity
Transcriptomic analysis of breast cancer patients sensitive and resistant to chemotherapy: Looking for overall survival and drug resistance biomarkersSemantic proximity
Select a neighboring publication to make it the new centre.